PD-010 Pharmacogenetics studies in patients with advanced lung cancer: Prognostic value of the thymidylate synthase 2R/3R polymorphism and predictivity of NER factor XPD K751Q and XRCC1 R399Q polymorphisms following platinum-based chemotherapy
Giachino, D., Ghio, P., Regazzoni, S., Mandrile, G., Novello, S., Selvaggi, G., De Marchi, M., Scagliotti, G.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80342-3
Date:
July, 2005
File:
PDF, 298 KB
english, 2005